You are invited to BioIVT’s complimentary symposium at the MassBioHub in Cambridge, MA discussing novel in vitro ADME research methodologies that may be incorporated into preclinical programs to guide lead selection and optimization and improve IVIVC.
Featuring researchers from academia, industry and BioIVT, this symposium will highlight the new ICH M12 regulatory guidance and present recently published studies and other data on how complex models are being used to investigate the ADME-Tox properties of new drugs.
Join us to learn more about how innovative models are being used to advance drug discovery and development programs as well as:
- Discover ideas that you can use in your research
- Uncover opportunities for collaboration
- Network with industry colleagues